Division of Allergy Pulmonary and Critical Care Medicine Archive — Page 1 of 13
-
February 6, 2026
Vanderbilt Health to lead expanded multisite study of immunomodulation in long COVID
The public health burden of long COVID is estimated to be the largest seen from an emerging disease in the past century, yet there remain no effective interventions. -
February 4, 2026
Broad genetic study reveals new drug target for asthma
The findings could bring relief to the more than 26 million people in the United States with asthma, a chronic and complex inflammatory disease of the airways. -
January 15, 2026
Immunometabolism may be a key to controlling sepsis: study
This discovery may lead to new ways to block metabolic changes contributing to excessive and ineffective inflammation, reset the immune system, and bring sepsis under control. -
January 5, 2026
Anna Hemnes named chair of Department of Medicine and system physician-in-chief for Vanderbilt Health
She will serve as the 11th chair of the Department of Medicine and system physician-in-chief for Vanderbilt Health. Her appointment was effective Jan. 1. -
December 10, 2025
Sedative choice could improve outcomes for breathing tube patients
It's the first study to demonstrate cardiovascular risks of high doses of ketamine (low blood pressure, arrhythmia), side effects that have not been well studied in the past. -
December 2, 2025
Ketamine fails surgical recovery trial
In a large, placebo-controlled, randomized trial, the pain reliever ketamine posed side effects while failing to aid patient recovery after major surgery. -
October 22, 2025
New sepsis therapy developed at VUMC edges closer to the clinic
Jacek Hawiger and his colleagues report that a “peptide genomic therapy” given in combination with an antibiotic nearly doubles survival rates from sepsis in an animal model, compared to treatment with antibiotic alone.